(Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 31, 2023 | (Q4)Jan 31, 2023 | (Q3)Oct 31, 2022 | (Q2)Jul 31, 2022 | (Q1)Apr 30, 2022 | (FY)Jan 31, 2022 | (Q4)Jan 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 91.64%-37.91K | 88.77%-82.74K | 40.66%-501.37K | -3.03%-2.82M | 18.63%-783.46K | 14.73%-453.37K | -30.83%-736.67K | -24.63%-844.9K | -116.30%-2.74M | -111.89%-962.89K |
Net income from continuing operations | 53.49%-453.96K | 29.67%-498.21K | 22.89%-613.88K | 5.61%-3.56M | 28.88%-1.08M | -28.40%-976.07K | -296.41%-708.36K | 39.38%-796.11K | -23.79%-3.78M | -26.07%-1.52M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 94.27%-1.85K | ---- |
Depreciation and amortization | -48.77%78.79K | --70.46K | 719.85%62.12K | 119.39%265.15K | -14.13%103.79K | --153.79K | --0 | --7.58K | --120.86K | --120.86K |
Remuneration paid in stock | ---- | ---- | ---- | -96.52%27.1K | 14,042.86%9.9K | --0 | ---- | ---- | -55.61%778.3K | -99.99%70 |
Change In working capital | -8.58%337.26K | 858.20%345.02K | 189.40%50.39K | 215.75%454.22K | -45.55%187.18K | 174.75%368.91K | 83.51%-45.51K | 3.21%-56.37K | 121.33%143.85K | 48.04%343.76K |
-Change in receivables | -100.45%-1.12K | 147.66%31.84K | 235.00%38.52K | 185.28%197.77K | ---37.55K | --250.99K | 131.72%12.86K | 51.12%-28.53K | -636.60%-231.9K | ---- |
-Change in prepaid assets | -37.94%31.25K | 6,080.86%70.63K | -27.21%11.75K | 138.90%108.31K | 171.47%43K | 65.45%50.36K | 99.54%-1.18K | 81.92%16.14K | -2,631.94%-278.41K | -494.49%-60.16K |
-Change in payables and accrued expense | 354.58%307.13K | 524.15%242.54K | 100.29%128 | -77.35%148.14K | -71.42%181.73K | 1,269.61%67.56K | -358.15%-57.18K | -403.16%-43.97K | 513.26%654.17K | 171.60%635.82K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 91.64%-37.92K | 88.77%-82.74K | 40.66%-501.37K | -3.03%-2.82M | 17.07%-783.46K | 22.13%-453.37K | -38.81%-736.67K | -24.63%-844.9K | -116.30%-2.74M | -107.89%-944.73K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | -38K | 189.2K | |||||||
Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---38K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---38K | --189.2K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 174.22%5.48M | 0 | |||||||
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 174.22%5.48M | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 174.22%5.48M | --0 |
Net cash flow | ||||||||||
Beginning cash position | -97.73%42.3K | -95.19%125.04K | -81.82%626.41K | 368.48%3.44M | -66.43%1.41M | -61.05%1.86M | -52.93%2.6M | 368.48%3.44M | 136,071.11%735.32K | 3,124.83%4.2M |
Current changes in cash | 91.64%-37.92K | 88.77%-82.74K | 40.66%-501.37K | -204.02%-2.82M | -3.70%-783.46K | 22.24%-453.37K | 0.50%-736.67K | -117.64%-844.9K | 268.75%2.71M | -224.87%-755.53K |
End cash Position | -99.69%4.39K | -97.73%42.3K | -95.19%125.04K | -81.82%626.41K | -81.82%626.41K | -66.43%1.41M | -61.05%1.86M | -52.93%2.6M | 368.48%3.44M | 368.48%3.44M |
Free cash from | 91.64%-37.92K | 88.77%-82.74K | 40.66%-501.37K | -1.62%-2.82M | -3.70%-783.46K | 22.24%-453.37K | 2.69%-736.67K | -24.63%-844.9K | -119.31%-2.77M | -66.26%-755.53K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data